ABBOTT DETERMINE TB LAM Ag
Rapid Rule-in TB-HIV co-infection
BENEFITS
- The Alere Determine™ TB LAM Ag test empowers you, at the point-of-care, to screen for active TB in HIV positive patients, providing results in just minutes.
- Offers optimal performance in HIV positive patients with advanced immunosuppression.
- A useful tool for detecting sputum smear negative patients.
- Diagnose both pulmonary and extra pulmonary TB from one convenient urine sample.
- Enhanced power comes through combination with methods such sputum smear microscopy or the Xpert® MTB/RIF test.
- Uses unprocessed urine as the validated sample type.
- An antigen (Ag) detection test, and detects the LAM antigen.
- LAM, lipoarabinomannan, is a structurally important component of the outer cell wall of mycobacteria that is shed from metabolically active or degrading cells, is cleared by the kidney and detectable in urine.
- Results in 25 minutes.
This novel rapid test detects the LAM antigen (lipoarabinomannan) in urine samples, assisting you in your TB screening to rule-in sooner than traditional methods and enabling earlier treatment for your patient.
